1) risedronic acid
利塞膦酸
1.
AIM:To evaluate the efficacy and safety of risedronic acid in the treatment of postmenopausal osteoporosis.
目的:探讨利塞膦酸治疗绝经后骨质疏松症的有效性和安全性。
2) risedronate sodium
利塞膦酸钠
1.
Study of the effect and safety of risedronate sodium for treatment of postmenopausal women with osteoporosis;
利塞膦酸钠对绝经后骨质疏松症的疗效与安全性研究
2.
Comparison of traditional Chinese medicine(Qiang-gu capsule) and Risedronate sodium in management of postmenopausal osteoporosis;
强骨胶囊与利塞膦酸钠治疗绝经后骨质疏松症的对比研究
3.
Analysis on influencing factor of effect for treating postmenopausal osteoporosis with risedronate sodium capsules
利塞膦酸钠胶囊治疗绝经后骨质疏松症疗效的影响因素分析
3) residronate sodium
利塞膦酸钠
1.
Objective:To evaluate the effect and safety of oral administration of residronate sodium in treatment of postmenopausal women with osteoporosis.
目的:探讨利塞膦酸钠治疗绝经后骨质疏松症的临床疗效,并评价其安全性。
4) risedronate
利塞膦酸钠
1.
Randomized,double-blind,multicenter comparative clinical trial of risedronate on bone mineral density in Chinese postmenopausal women;
利塞膦酸钠对绝经后妇女骨密度影响的随机双盲多中心对照临床研究
2.
A randomized double-blind placebo-control clinical study of risedronate in prevention and treatment for postmenopausal osteoporosis;
利塞膦酸钠防治绝经后妇女骨质疏松症的对照试验
3.
Effects of Risedronate on the expression of tumor necrosis factor alpha and osteoprotegrin in human osteoblastic-like MG 63 cell lines.;
利塞膦酸钠对人成骨样细胞MG63 OPG及TNFα表达的影响
5) Risedronate Sodium
利塞膦酸盐
1.
Risedronate Sodium effect of the osteogenesis induced by bone mesenchymal stem cells on decalcification bone scaffolds
利塞膦酸盐对BMSCs诱导的成骨细胞在脱钙骨支架上生物学行为的影响
6) Risedremate Sodium
利噻膦酸钠
补充资料：利塞膦酸
分子式：C7H11NO7P2
分子量：暂无
CAS号：105462-24-6
性质：暂无
制备方法：暂无
用途：钙调节药。
分子量：暂无
CAS号：105462-24-6
性质：暂无
制备方法：暂无
用途：钙调节药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条